As per MRFR analysis, the India Gene Expression Analysis Market Size was estimated at 171.86 (USD Million) in 2023. The India Gene Expression Analysis Market is expected to grow from 189.6 (USD Million) in 2024 to 747.7 (USD Million) by 2035. The India Gene Expression Analysis Market CAGR (growth rate) is expected to be around 13.285% during the forecast period (2025 - 2035).
Increased research in molecular biology and genomics is propelling the India gene expression analysis market's notable expansion. As a powerful market driver, the Indian government has been supporting programs like the National Biotechnology Development Strategy, which aims to advance biotechnology and life sciences.
This assistance results in more money being allocated to infrastructure development and research initiatives in both the public and commercial sectors. Furthermore, a favourable environment for technological improvement and knowledge sharing in gene expression analysis is being created by the growing number of cooperation between Indian academic institutions and international organisations.
A growing emphasis on genomics-based diagnostics and targeted medicines in India's healthcare system presents numerous opportunities in the field of personalised medicine. A strong argument for using gene expression analysis is made by the rising incidence of chronic illnesses and the demand for specialised treatment alternatives.
Additionally, new products and services in gene expression analysis that serve both domestic and foreign markets are made possible by the revival of the biotechnology industry in India, which is being driven by the government's Make in India initiative.
Recent years have seen a discernible shift in gene expression research towards automation and the use of cutting-edge technology like artificial intelligence and machine learning. This tendency is speeding up research and improving data analysis skills.
Furthermore, the need for trustworthy gene expression analysis tools is expected to grow as more people become aware of the benefits of genetic testing for a range of illnesses. The Indian biotechnology framework's emphasis on quality standards and regulatory compliance is also influencing the market environment by guaranteeing that goods fulfil global standards.
Overall, an ecosystem that encourages innovation and research is expected to propel significant developments in the India Gene Expression Analysis Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The increasing rate of cancer cases and genetic disorders in India is a significant driver for the India Gene Expression Analysis Market. The National Cancer Registry Programme of India indicated that there are over 1 million new cancer cases reported annually, with projections suggesting a more than 5% increase each year.
This alarming statistic emphasizes the urgent need for advanced diagnostic tools, including gene expression analysis, to enable early detection and personalized treatment strategies. Organizations like the Tata Memorial Centre are actively involved in cancer research and treatment, fostering the development of gene expression analysis technologies to improve patient outcomes.
Furthermore, the Government of India has also initiated various health programs to enhance cancer research, thereby increasing funding and collaboration opportunities for gene expression analysis, which is expected to drive market growth significantly.
In India, there has been a substantial increase in investments towards Research and Development (R&D), which is critical for the advancement of the gene expression analysis sector. According to the Department of Science and Technology, the allocation for biotechnology research by the government has increased by over 12% in recent years.
Established institutions like the Indian Institute of Science are focusing on innovative projects aimed at expanding the applications of gene expression analysis across diagnostics and therapeutics. This surge in R&D investment makes it easier for startups and established companies to delve into gene expression analysis, thus contributing to the overall growth of the India Gene Expression Analysis Market.
The Indian government has been implementing several initiatives to enhance the biotechnology sector, which includes gene expression analysis. The Biotechnology Industry Research Assistance Council (BIRAC) has been established to promote innovation and entrepreneurship in the biotechnology space, providing funding and support to startups focusing on gene analysis technologies.
Additionally, the 'Make in India' campaign has encouraged local manufacturing of biotechnological products, including gene expression analysis tools. This government backing plays a vital role in stimulating the growth of the India Gene Expression Analysis Market as it fosters an ecosystem that attracts both local and international investments.
The 'End-User' segment of the India Gene Expression Analysis Market plays a pivotal role in the overall landscape, driven primarily by its diverse applications across various sectors such as pharmaceuticals, biotechnology, academia, and contract research organizations.
Pharmaceutical and biotechnology companies have emerged as significant contributors, leveraging gene expression analysis for drug development, personalized medicine, and therapeutic interventions, reflecting the industry’s need for precise genomic data to accelerate innovation and improve treatment outcomes.
Academic and research institutes are also key players, focusing on fundamental scientific research, which is essential for advancing understanding in genomics, molecular biology, and biochemistry. They contribute substantially to the knowledge base, often collaborating with industry stakeholders to facilitate breakthroughs in gene expression studies.
Contract research organizations provide specialized services that support pharmaceutical and biotechnology firms in navigating complex regulatory landscapes and detailed data analysis, making them indispensable in the research and development (R&D) lifecycle.
The 'Others' category encompasses a range of entities, including government laboratories and non-profits, that offer essential research capabilities and foster innovation through public-private partnerships.
Overall, the End-User segment showcases a strong inclination towards integrating cutting-edge technologies, such as bioinformatics and high-throughput screening, to enhance productivity and efficiency in gene expression analysis. With the growing number of research initiatives and increasing funding from both public and private sectors in India, the demands for gene expression analysis services are expected to rise, further driving the market dynamics in this segment.
The infrastructure and investment inputs from the Indian government in genomic research and its applications are also crucial in fostering an environment conducive to growth, thereby positioning the End-User segment as a cornerstone of the evolving Indian Gene Expression Analysis Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The India Gene Expression Analysis Market demonstrates substantial growth potential, particularly within the Product segment, which encompasses Consumables and Instruments. Consumables refer to the vital reagents and kits necessary for conducting gene expression analysis experiments, making them an essential component of laboratory operations.
Their recurring need ensures a steady demand as more research laboratories expand in India, driven by increasing investments in biotechnology and personalized medicine. Instruments, on the other hand, include advanced technologies such as qPCR machines, microarrays, and next-generation sequencing equipment, which are indispensable for accurate and efficient data collection.
The market's robustness is further fueled by the country's rising focus on genomics research, increased funding from government initiatives, and collaborations with private organizations.
This growing emphasis on precision medicine and customized healthcare is expected to spur innovation and adoption of novel instruments and consumables, reinforcing their significance in the India Gene Expression Analysis Market.
As the landscape evolves, the integration of cutting-edge technologies and the expansion of research capabilities will contribute tangibly to unlocking further opportunities within this sector.
The Application segment of the India Gene Expression Analysis Market plays a critical role in advancing various domains within the life sciences. Notably, Drug Discovery, Diagnosis, and Research form the core of this segment, enabling significant progress in understanding the genetic and molecular mechanisms of diseases.
Drug Discovery leverages gene expression analysis to identify potential therapeutic targets and biomarkers, hence improving efficacy and safety profiles. Meanwhile, the Diagnostic application is increasingly essential as it aids in the early detection and personalized treatment of diseases, thus enhancing patient outcomes.
Additionally, Research contributes extensively to expanding scientific knowledge, driving innovations in genomics and molecular biology. As the demand for precision medicine grows, these applications are expected to gain further momentum in India, particularly in light of the country's emphasis on biotechnology and genomics research.
Substantial investments and government initiatives in life sciences are likely to foster growth in these areas, amplifying their significance in the India Gene Expression Analysis Market landscape. The rising collaboration between academic institutions and industry players boosts the overall innovation pipeline, ensuring that India remains at the forefront of genetic research and application.
The Service segment of the India Gene Expression Analysis Market encompasses various critical offerings that play a vital role in advancing genomics research and applications. Gene Expression Profiling Services are essential in allowing researchers to understand gene activity levels across different conditions, aiding in the identification of biomarkers and therapeutic targets.
Sequencing Services offer comprehensive genomic insights, facilitating the analysis of genetic variations that can drive personalized medicine and targeted therapy.
Bioinformatics Solutions are increasingly significant, providing sophisticated data analysis and interpretation capabilities necessary to manage the large volumes of data generated through sequencing and profiling, thus transforming data into actionable insights.
The Others category captures additional services that support research and clinical practices, which are gaining prominence as the demand for customization and efficiency in gene expression analysis continues to rise.
The growth of this segment, influenced by an increased focus on Research and Development by Indian biotech firms and academic institutions, reflects a broader trend in the country emphasizing precision healthcare and innovative therapeutic solutions. These services collectively drive advancements in understanding complex diseases, enhancing the value of the India Gene Expression Analysis Market.
The India Gene Expression Analysis Market is experiencing significant growth driven by advancements in genomic technologies and the increasing awareness of personalized medicine.
As a critical aspect of molecular biology, gene expression analysis involves studying the transcription of genes and understanding their regulation, providing insights into various biological processes and disease mechanisms.
This market comprises a diverse range of players, from established global companies to emerging local firms, all vying for a share in this dynamic landscape. Competitive insights indicate a landscape characterized by innovation, strategic partnerships, and continuous product development aimed at enhancing research capabilities in genomics and clinical applications.
The demand for gene expression analysis tools is growing across pharmaceutical companies, research institutions, and diagnostic laboratories, leading to strategic collaborations and technology investments in this space.
Illumina stands out prominently within the India Gene Expression Analysis Market due to its strong presence and extensive product portfolio tailored to meet the diverse needs of researchers and clinicians. The company's advanced sequencing technologies and platforms facilitate accurate gene expression profiling, making it a preferred choice for many scientific endeavors.
Illumina's robust distribution network and local partnerships in India have enabled the company to establish a substantial market footprint. Its commitment to innovation ensures a steady stream of cutting-edge products bolstered by strong technical support and training services that enhance user experience and client satisfaction.
This dedication to customer engagement and rapid response to technological advancements gives Illumina a competitive edge in the rapidly evolving landscape of gene expression analysis.
Bioneer is another key player within the India Gene Expression Analysis Market, recognized for its innovative approach and comprehensive range of products and services focused on molecular biology research. The company delivers user-friendly and high-quality solutions, including its proprietary kits and reagents for gene expression analysis that cater to researchers in various fields.
Bioneer's strategic market positioning in India is reinforced through collaborations with local research institutions and universities that leverage its technologies for academic and clinical research. The firm has made headlines with its tailored offerings and robust customer support, making it a go-to partner for laboratories exploring gene expression studies.
Through targeted mergers and acquisitions, Bioneer has been expanding its capabilities and enhancing its product offerings, which positions it to address the growing demands in the market effectively, ensuring a strong and sustainable presence in the competitive landscape of gene expression analysis in India.
The India Gene Expression Analysis Market has witnessed significant developments recently, with various companies expanding their operations and product offerings. In October 2023, Illumina launched a new sequencing technology aimed at enhancing genomic research capabilities in India.
Thermo Fisher Scientific also announced collaborations with Indian research institutions to improve gene expression studies in oncology. In terms of mergers and acquisitions, in May 2023, Roche acquired a local biotechnology startup to bolster its gene expression analysis portfolio.
Qiagen has been actively increasing its market presence in India by establishing strategic partnerships with educational institutions for collaborative research initiatives. The market has seen substantial growth, driven by rising investments in biotechnology and increasing demand for personalized medicine.
In September 2022, BioRad Laboratories reported a significant investment in infrastructure to expand its gene expression analysis capabilities within the region. Additionally, the Indian government has been promoting genomic research through various initiatives, reflecting the growing importance of gene analysis in medical and agricultural applications.
Overall, the gene expression analysis sector in India is evolving rapidly, marked by innovation, collaborations, and increased funding.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 171.86(USD Million) |
| MARKET SIZE 2024 | 189.6(USD Million) |
| MARKET SIZE 2035 | 747.7(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 13.285% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Illumina, Bioneer, Roche, GSK, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Zymo Research, Merck KGaA, PerkinElmer, Genomatix, NantHealth, BioRad Laboratories, Pacific Biosciences |
| SEGMENTS COVERED | End-User, Product, Application, Service |
| KEY MARKET OPPORTUNITIES | Rising demand for personalized medicine, Growth in biotechnology research, Increasing investments in genomics, Advancements in sequencing technologies, Expanding applications in drug discovery |
| KEY MARKET DYNAMICS | Increasing demand for personalized medicine, Advancements in biotechnology tools, Growing research funding and investment, Rising prevalence of genetic diseases, Expanding applications in drug discovery |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Gene Expression Analysis Market is expected to be valued at 189.6 million USD in 2024.
By 2035, the India Gene Expression Analysis Market is projected to reach a valuation of 747.7 million USD.
The market is expected to grow at a CAGR of 13.285% from 2025 to 2035.
In 2035, Pharmaceutical & Biotechnology Companies are projected to dominate the market with a valuation of 295.0 million USD.
The market value for Academic & Research Institutes is expected to be 168.0 million USD in 2035.
Challenges may include the high costs associated with advanced technology and variations in regulatory compliance.
Major players include Illumina, Roche, Thermo Fisher Scientific, and Qiagen among others.
The market value for Contract Research Organizations is anticipated to be 47.6 million USD in 2024.
There are opportunities in expanding research applications and advancements in gene technology.
The 'Others' category is expected to reach 93.7 million USD by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
